Other
Income Taxes Paid, Net
Alnylam Pharmaceuticals Income Taxes Paid, Net increased by 85.5% to $2.37M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 20.2%, from $2.97M to $2.37M. Over 2 years (FY 2022 to FY 2024), Income Taxes Paid, Net shows an upward trend with a 132.6% CAGR.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
Metric ID:
ms_income_taxes_paid_netHistorical Data
16 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $663.50K | $663.50K | $663.50K | $663.50K | $1.51M | $1.51M | $1.51M | $1.51M | $1.99M | $1.57M | $4.61M | $6.19M | $2.97M | -$1.87M | $1.28M | $2.37M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +126.9% | +0.0% | +0.0% | +0.0% | +32.0% | -20.8% | +192.7% | +34.4% | -52.1% | -163.0% | +168.3% | +85.5% |
| YoY Change | — | — | — | — | +126.9% | +126.9% | +126.9% | +126.9% | +32.0% | +4.6% | +206.1% | +311.4% | +49.4% | -218.9% | -72.3% | -20.2% |
Range-$1.87M – $6.19M
CAGR+40.4%
Avg YoY Growth+66.6%
Median YoY Growth+88.1%
Current Streak2 quarters growth
Income Taxes Paid, Net at Other Companies
Frequently Asked Questions
- What is Alnylam Pharmaceuticals's income taxes paid, net?
- Alnylam Pharmaceuticals (ALNY) reported income taxes paid, net of $2.37M in Q1 2026.
- How has Alnylam Pharmaceuticals's income taxes paid, net changed year-over-year?
- Alnylam Pharmaceuticals's income taxes paid, net decreased by 20.2% year-over-year, from $2.97M to $2.37M.
- What is the long-term trend for Alnylam Pharmaceuticals's income taxes paid, net?
- Over 2 years (2022 to 2024), Alnylam Pharmaceuticals's income taxes paid, net has grown at a 132.6% compound annual growth rate (CAGR), from $2.65M to $14.36M.